Page 579 - The Toxicology of Fishes
P. 579

Chemical Carcinogenesis in Fishes                                           559


                       v-erbA fragments have been reported in Xiphophorus (Zechel et al., 1989). Sequence analysis of two
                       erbA homologs revealed two different Xiphophorus hormone receptors homologs to the human retinoic
                       acid receptor and the human thyroid hormone receptor.
                        C-fos functions as a transcription factor, and the fos oncogene has been reported in osteosarcomas
                       and chondrosarcomas in mice (Finkel et al., 1975). Increased expression of the fos oncogene has been
                       reported in DEN-induced hepatic neoplasms from Rivulus species (Goodwin and Grizzle, 1994a,b), and
                       c-fos-related genes have been induced by neural activation in rainbow trout brain (Matsuoka et al., 1988).
                       A c-fos-like protein has also been reported in pufferfish (Fugu rubripes) (Trower et al., 1996).

                       Class VIII Oncogenes: Unclassified
                       Oncogenes have now been reported among mammalian models that are of unknown function or do not
                       fit a previously define class (e.g., dbl, bcl-2). To date, although oncogenes of this type undoubtedly exist
                       among fish, they have not been reported; however, methods have been developed to assess the trans-
                       forming ability of fish tumor DNA via transfection in NIH3T3 cells followed by assessment of tumor-
                       igenicity by the nude mouse assay (reviewed in Van Beneden and Ostrander, 1994). This method holds
                       promise for the identification of new oncogenes in fish, as does differential-display polymerase chain
                       reaction (ddPCR) of tumor samples and cDNA arrays.


                       Tumor Suppressor Genes
                       Although mutations in oncogenes have been shown to lead to gain of function and activate cell prolif-
                       eration, tumor suppressor genes lead to a loss of function and act to negatively regulate cell growth and
                       differentiation (Ruddon, 1995). In the simplest form, mutational events (e.g., point mutations and
                       deletions) lead to synthesis of nonfunctioning proteins and as such normal pathways responsible for cell
                       proliferation, growth, and differentiation are inactivated; for example, p53 acts as a transcription factor,
                       causing cells to be eliminated by apoptosis upon its activation by irreparable DNA damage, overly
                       expressed oncogenes, or many other stresses. Its loss of function may allow a cell to progress inappro-
                       priately through cell cycle checkpoints.
                        The first tumor suppressor gene to be identified was the retinoblastoma tumor suppressor gene and,
                       as discussed below, it was subsequently reported in a number of fish species. Among humans and other
                       mammalian models, significantly fewer tumor suppressor genes have been identified compared to
                       oncogenes (approximately 60), and of these only a few have been reported in fishes. Detailed below are
                       a few of the most frequently studied tumor suppressor genes in teleost models. As was the case for the
                       oncogenes above, this is not intended to be an exhaustive list of those identified in fish, and new ones
                       are being identified on a regular basis. The interested reader is again referred to GenBank. Discussion
                       of a unique oncogene–tumor suppressor gene interaction in Xiphophorus is detailed later in this chapter.

                       Class I Tumor Suppressor Genes: Nuclear Transcription Factors
                       Retinoblastoma Gene
                       Retinoblastomas are eye tumors that arise from the retinoblasts along the margins of the developing
                       retina. Among humans, these tumors only occur in the first 1 to 2 years of life before retina development
                       is complete. Mutations in the retinoblastoma tumor suppressor gene (Rb) have been found in nearly all
                       retinoblastomas examined and in quite a few other types of cancers, including osteosarcomas, prostate,
                       breast, cervical, lung, and various leukemias (reviewed in Hesketh, 1997). The Rb gene product (pl05Rb)
                       is a nuclear phosphoprotein with DNA-binding ability. During the cell cycle, p105Rb remains hypo-
                       phosphorylated during the early G  phase, undergoes sequential phosphorylation as the cell enters S
                                                  1
                       phase, progresses through G , and enters mitosis before becoming again dephosphorylated (DeCaprio
                                             2
                       et al., 1988). Available data suggest that the hypophosphorylated form of the Rb protein may bind with
                       other proteins responsible for DNA synthesis. Thus, alterations in translation or transcription will lead
                       to altered forms of the gene product incapable of binding these proteins and DNA synthesis and ultimately
                       cell proliferation will remain unchecked.
   574   575   576   577   578   579   580   581   582   583   584